Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease

INTRODUCTION: Many Luminal breast cancers are heterogeneous, containing substantial numbers of estrogen (ER) and progesterone (PR) receptor-negative cells among the ER+ PR+ ones. One such subpopulation we call “Luminobasal” is ER-, PR- and cytokeratin 5 (CK5)-positive. It is not targeted for treatme...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Knox, Aaron J, Scaling, Allison L, Pinto, Mauricio P, Bliesner, Brian S, Haughian, James M, Abdel-Hafiz, Hany A, Horwitz, Kathryn B
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187339/
https://ncbi.nlm.nih.gov/pubmed/25116921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0418-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы